Jürgen Römisch

3.3k total citations
76 papers, 2.7k citations indexed

About

Jürgen Römisch is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Jürgen Römisch has authored 76 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 28 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Jürgen Römisch's work include Blood Coagulation and Thrombosis Mechanisms (24 papers), S100 Proteins and Annexins (15 papers) and Hemophilia Treatment and Research (13 papers). Jürgen Römisch is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (24 papers), S100 Proteins and Annexins (15 papers) and Hemophilia Treatment and Research (13 papers). Jürgen Römisch collaborates with scholars based in Germany, Austria and United States. Jürgen Römisch's co-authors include Robert Huber, Eric P. PÂQUES, Monika Schneider, Andrea Heger, Annette Feussner, N. Heimburger, Irmgard Mayr, Christian J. Wiedermann, Robert Berendes and Stefan Dunzendorfer and has published in prestigious journals such as The EMBO Journal, Blood and Journal of Molecular Biology.

In The Last Decade

Jürgen Römisch

76 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jürgen Römisch Germany 28 1.4k 869 398 282 238 76 2.7k
Gerry A. F. Nicolaes Netherlands 34 991 0.7× 1.9k 2.2× 945 2.4× 249 0.9× 221 0.9× 114 4.1k
Bayard Clarkson United States 22 1.5k 1.1× 1.9k 2.1× 538 1.4× 245 0.9× 524 2.2× 43 4.9k
Joseph R. Slupsky United Kingdom 29 1.5k 1.1× 984 1.1× 1.3k 3.3× 321 1.1× 279 1.2× 61 4.2k
Kylie D. Mason Australia 18 2.4k 1.8× 908 1.0× 948 2.4× 247 0.9× 213 0.9× 58 4.0k
Alan R. Stafford Canada 32 843 0.6× 935 1.1× 236 0.6× 233 0.8× 412 1.7× 74 2.6k
S Paul Bajaj United States 38 756 0.6× 2.4k 2.8× 198 0.5× 291 1.0× 495 2.1× 95 3.6k
Hans Minderman United States 34 1.7k 1.2× 396 0.5× 622 1.6× 450 1.6× 187 0.8× 90 3.2k
Peter N. Walsh United States 36 441 0.3× 2.0k 2.3× 395 1.0× 272 1.0× 573 2.4× 104 3.5k
BC Furie United States 25 728 0.5× 1.4k 1.6× 572 1.4× 245 0.9× 298 1.3× 39 3.1k
Stephanie Halene United States 27 2.0k 1.4× 662 0.8× 849 2.1× 402 1.4× 209 0.9× 111 3.8k

Countries citing papers authored by Jürgen Römisch

Since Specialization
Citations

This map shows the geographic impact of Jürgen Römisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Römisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Römisch more than expected).

Fields of papers citing papers by Jürgen Römisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Römisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Römisch. The network helps show where Jürgen Römisch may publish in the future.

Co-authorship network of co-authors of Jürgen Römisch

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Römisch. A scholar is included among the top collaborators of Jürgen Römisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Römisch. Jürgen Römisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Volk, Andreas, et al.. (2021). SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin. BioDrugs. 36(1). 41–53. 25 indexed citations
2.
Schulz, Petra, Sebastian Müller, Torben Dall Schmidt, et al.. (2018). Biochemical characterization, stability, and pathogen safety of a new fibrinogen concentrate (fibryga ® ). Biologicals. 52. 72–77. 20 indexed citations
3.
Heger, Andrea, et al.. (2013). Universal pooled plasma (Uniplas®) does not induce complement-mediated hemolysis of human red blood cells in vitro. Transfusion and Apheresis Science. 52(1). 128–135. 6 indexed citations
4.
Hillarp, Andreas, et al.. (2010). Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol. Journal of Thrombosis and Haemostasis. 8(10). 2216–2223. 25 indexed citations
5.
Jacobi, Christian, Maren Claus, Brigitte Wildemann, et al.. (2009). Exposure of NK cells to intravenous immunoglobulin induces IFNγ release and degranulation but inhibits their cytotoxic activity. Clinical Immunology. 133(3). 393–401. 41 indexed citations
8.
Pabinger, Ingrid, et al.. (2005). Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays. Journal of Immunological Methods. 308(1-2). 90–100. 19 indexed citations
9.
Römisch, Jürgen, et al.. (2002). Antithrombin III inhibits nuclear factor κB activation in human monocytes and vascular endothelial cells. Blood. 99(11). 4015–4020. 123 indexed citations
10.
Römisch, Jürgen, Harald M. Stauss, D. Inthorn, et al.. (2002). Quantification of Antithrombin Isoform Proportions in Plasma Samples of Healthy Subjects, Sepsis Patients, and in Antithrombin Concentrates. Pathophysiology of Haemostasis and Thrombosis. 32(3). 143–150. 17 indexed citations
11.
Gröner, Albrecht, Thomas Nowak, & Jürgen Römisch. (2002). Purity, Activity, and Virus Safety of a Pasteurized Antithrombin Concentrate. Seminars in Thrombosis and Hemostasis. 28(S1). 79–86. 8 indexed citations
12.
Römisch, Jürgen, et al.. (2001). Separation of antithrombin III variants by micellar electrokinetic chromatography. Journal of Chromatography A. 924(1-2). 307–313. 12 indexed citations
13.
Bastian, Boris C., et al.. (1993). Localization of annexins in normal and diseased human skin. Journal of Dermatological Science. 6(3). 225–234. 25 indexed citations
14.
Pâques, Eric-Paul, Melitta Just, Gerald Reiner, & Jürgen Römisch. (1992). Pharmacological and pharmacokinetic properties of a deglycosylated mutant of the tissue-type plasminogen activator expressed in CHO cells. Fibrinolysis and Proteolysis. 6(2). 125–130. 7 indexed citations
15.
Pâques, Eric-Paul, Hermann Erich Karges, & Jürgen Römisch. (1992). Prevention of fibrinogenolysis without impairment of thrombolysis: Combination of A Plasminogen Activator with a2-antiplasmin. Fibrinolysis and Proteolysis. 6(2). 111–117. 1 indexed citations
16.
Römisch, Jürgen, et al.. (1991). Annexins: calcium-binding proteins of multi-functional importance?. Medical Microbiology and Immunology. 180(3). 109–26. 54 indexed citations
17.
Römisch, Jürgen, et al.. (1991). Comparative study on the in vitro effectiveness of antithrombotic agents. Thrombosis Research. 64(1). 11–21. 30 indexed citations
18.
Römisch, Jürgen, et al.. (1991). In-vivo antithrombotic potency of Placenta Protein 4 (annexin V). Thrombosis Research. 61(2). 93–104. 59 indexed citations
19.
Römisch, Jürgen, et al.. (1991). [Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect].. PubMed. 42(7). 417–23. 1 indexed citations
20.
Römisch, Jürgen, et al.. (1990). Anticoagulant properties of placenta protein 4 (Annexin V). Thrombosis Research. 60(5). 355–366. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026